药物治疗在阻塞性睡眠呼吸暂停中的新兴作用
Nikhil Jaganathan1, Younghoon Kwon2, William J Healy3
1Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
概括
新的药物类别显示出治疗阻塞性睡眠呼吸暂停 (OSA) 的前景. 呼吸系统兴奋剂和GLP-1受体激动剂可能为CPAP提供有效的替代品,用于管理这种常见的睡眠障碍.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
- 睡眠医学 睡眠医学
背景情况:
- 阻塞性睡眠呼吸暂停 (OSA) 是一种广泛存在的疾病,治疗耐受性有限.
- 持续正气道压力 (CPAP) 是标准的,但由于副作用,需要替代方案.
- 药物治疗为OSA管理提供了一个潜在的途径.
研究的目的:
- 审查阻塞性睡眠呼吸暂停的新兴药物治疗方法.
- 探索呼吸系统兴奋剂和GLP-1受体激动剂的机制和疗效.
- 讨论这些药物类别在OSA治疗中的未来潜力.
主要方法:
- 对OSA的药理学药物的现有文献进行叙述性审查.
- 对noradrenergic-antimuscarinic组合和GLP-1RAs的初步研究的分析.
- 讨论药物机制,当前数据和未来前景.
主要成果:
- 诺亚上腺素-抗肌素组合通过刺激呼吸道肌肉和降低呼吸暂停-呼吸暂停指数 (AHI) 显示出潜在的潜力.
- 葡萄糖类1受体激动剂 (GLP-1RAs) 通过减肥和AHI降低表现出有效性.
- 初步数据表明,这些药物可显著改善AHI和氧和度.
结论:
- 药物治疗,包括呼吸道刺激剂和GLP-1RAs,为OSA治疗提供了有前途的替代方案.
- 这些药物可以改善呼吸道通透性并减少OSA的严重程度.
- 需要进一步的研究来确定这些新型治疗方法的长期疗效和安全性.
相关概念视频
Sleep Apnea
128
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
128
Management of Insomnia
231
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
231
Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
172
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
172
Sedatives and Hypnotics Drugs: Miscellaneous Agents
146
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
146
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K


